Literature DB >> 1097573

Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens.

R C Lancefield, M McCarty, W N Everly.   

Abstract

The data presented in this paper establish the finding that multiple specific protective antibodies exist in rabbits in response to immunization with Group B streptococci. The summary in Table I indicates the serological types into which Group B streptococci have been divided on the basis of their antigenic composition. This classification is dependent upon passive protection of mice with antibodies directed against the specific antigens, and types are defined in these terms. Heretofore, it was thought that type-specific polysaccharides accounted for all such protection in Group B streptococci. Certain exceptions of cross-protection between types due to minor polysaccharide determinants soon appeared; cross-protection reactions based on protein determinants in at least two types were also discovered. The present experiments show that specific antibodies directed to either polysaccharide or protein antigens of a single strain can be protective against infection with streptococci containing these antigens.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1097573      PMCID: PMC2189884          DOI: 10.1084/jem.142.1.165

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  Type classification by Lancefield's precipitin method of human and bovine group-B streptococci isolated in Britain.

Authors:  I H PATTISON; P R MATTHEWS; W R MAXTED
Journal:  J Pathol Bacteriol       Date:  1955 Jan-Apr

2.  Occurrence of the M. substance of type 28 group A in streptococci of Lancefield groups B, C and G.

Authors:  W R MAXTED
Journal:  J Gen Microbiol       Date:  1949-01

3.  The isolation and some physiochemical and biologic properties of the type 3 antigen of group B streptococci.

Authors:  H Russell; N L Norcross
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

4.  Type classification of the group B streptococci by means of Lancefield's precipitin method. Classification of strains of bovine and human origin; isolated during the year 1971 in Norway.

Authors:  R H Haug
Journal:  Nord Vet Med       Date:  1972-12

5.  Type-specific polysaccharide antigens of group B streptococci.

Authors:  R C Lancefield; E H Freimer
Journal:  J Hyg (Lond)       Date:  1966-06

6.  Immunochemistry of purified polysaccharide type antigens of group B streptococcal types Ia, Ib, and Ic.

Authors:  H W Wilkinson
Journal:  Infect Immun       Date:  1975-04       Impact factor: 3.441

7.  Distribution by serological type of group B streptococci isolated from a variety of clinical material over a five-year period (with special reference to neonatal sepsis and meningitis).

Authors:  H W Wilkinson; R R Facklam; E C Wortham
Journal:  Infect Immun       Date:  1973-08       Impact factor: 3.441

8.  Type-specific antigens of group B type Ic streptococci.

Authors:  H W Wilkinson; R G Eagon
Journal:  Infect Immun       Date:  1971-11       Impact factor: 3.441

9.  New approaches for the laboratory recognition of M types of group A streptococci.

Authors:  J Rotta; R M Krause; R C Lancefield; W Everly; H Lackland
Journal:  J Exp Med       Date:  1971-11-01       Impact factor: 14.307

10.  A SEROLOGICAL DIFFERENTIATION OF SPECIFIC TYPES OF BOVINE HEMOLYTIC STREPTOCOCCI (GROUP B).

Authors:  R C Lancefield
Journal:  J Exp Med       Date:  1934-03-31       Impact factor: 14.307

View more
  171 in total

1.  New serotypes of group B streptococci isolated from human sources.

Authors:  B Perch; E Kjems
Journal:  J Clin Microbiol       Date:  1979-07       Impact factor: 5.948

2.  Role of antibody and complement in opsonization of group B streptococci.

Authors:  A O Shigeoka; R T Hall; V G Hemming; C D Allred; H R Hill
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

3.  Opsonic effect of jacalin and human immunoglobulin A on type II group B streptococci.

Authors:  N R Payne; N F Concepcion; B F Anthony
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

4.  Localization of surface immunogenic protein on group B streptococcus.

Authors:  S Rioux; D Martin; H W Ackermann; J Dumont; J Hamel; B R Brodeur
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

5.  The potential use of monoclonal antibodies as therapeutic modalities in neonatal infection.

Authors:  H R Hill; L A Gonzales; D K Kelsey; H V Raff
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer

6.  Antibody-independent and -dependent opsonization of group B Streptococcus requires the first component of complement C1.

Authors:  N J Levy; D L Kasper
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

7.  Functional characteristics of a modified immunoglobulin preparation for intravenous administration: summary of studies of opsonic and protective activity against group B streptococci.

Authors:  G W Fischer; S R Wilson; K W Hunter
Journal:  J Clin Immunol       Date:  1982-04       Impact factor: 8.317

8.  Association of type- and group-specific antigens with the cell wall of serotype III group B streptococcus.

Authors:  T I Doran; S J Mattingly
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

9.  Estimation of group B streptococcus type III polysaccharide-specific antibody concentrations in human sera is antigen dependent.

Authors:  R Bhushan; B F Anthony; C E Frasch
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

10.  Murine monoclonal antibodies to type Ib polysaccharide of group B streptococci bind to human milk oligosaccharides.

Authors:  D G Pritchard; B M Gray; M L Egan
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.